Loading the records…
Loading the records…
HR 7417, the Women's Heart Health Expansion Act of 2026, is an early-stage authorization bill reauthorizing the WISEWOMAN program at $250M over five years. It has no near-term market impact because it only sets a spending ceiling, no funds are appropriated, and no publicly traded companies are named as grantees. The bill is referred to committee with 23 cosponsors and no legislative velocity.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
No measurable market implications. This bill does not affect any publicly traded company's revenue, costs, or competitive position at this stage. The $250 million authorization is entirely for public health program grants to state and local entities, not for corporate procurement or reimbursement changes.
On February 9, 2026, Rep. Beatty (D-OH) introduced H.R. 7417, amending the Public Health Service Act to reauthorize the WISEWOMAN program, which provides preventive heart health services (blood pressure and cholesterol screenings, health education) and referrals for low-income women. The bill has been referred to the House Committee on Energy and Commerce and has 23 cosponsors — a relatively low number for significant healthcare legislation. As of April 30, 2026, no further action has occurred.
The bill authorizes up to $250 million for fiscal years 2027 through 2031 — that is a ceiling, not actual funding. Authorization bills do not allocate money; actual appropriations require a separate, subsequent bill. The WISEWOMAN program distributes grants to state and local health departments and community health centers, not to publicly traded companies. No corporate beneficiaries are named or implied in the text.
There are no structural winners or losers among publicly traded companies. The WISEWOMAN program targets low-income women through non-profit and government-run screening entities. Private diagnostic labs or cardiovascular device manufacturers — such as Abbott Laboratories (ABT), Medtronic (MDT), or Boston Scientific (BSX) — are not directly funded or mandated by this bill. The mechanism is entirely grant-based with no procurement requirements for specific products.
No real market data is available for analysis. The healthcare sector's performance is not correlated with this procedural, early-stage authorization bill.
The legislative path is long: committee markup, House floor vote, Senate introduction and passage, conference committee (if Senate passes a different version), and then a separate appropriations process. Given the 119th Congress is at its midpoint (2026), the timeline for final passage and funding is uncertain. The slight Democratic sponsorship and narrow scope suggest low bipartisan urgency.
Matched on shared policy language across AI analyses, with ticker & timing weight
Executive orders & memoranda affecting the same sectors or companies
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →